Allarta is a life science start-up with a novel delivery platform of immune-privileged materials, that enable cell and stem cell therapies for the treatment of diabetes and other endocrine disorders.

With pre-seed funding from McMaster University and investors Mark Krembil and Ian Delaney, the SOPHIE collaboration will now enable further pre-clinical studies, paving Allarta’s path to the clinic and it’s goal of treating patients.